Why Put The "N" in Nplate?
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA clinical reviewers had cold feet over Amgen's choice of Nplate as the trade name for its thrombopoeitin receptor agonist romiplostim, review documents show, but Amgen's argument that the brand name furthered its attempt to secure a global trademark carried the day